Different industries. Different content. The same transformation skill: dense business material rebuilt as native, editable PowerPoint.
The source contained the evidence.
The redesign had to reveal the contradiction.
A dense vaccine-innovation discussion reframed as a 10-slide visual diagnosis.
2
3
4
5
6
7
8
This PowerPoint transformation reframes a 40-slide vaccine-innovation discussion into a focused 10-slide narrative.
The source contained strong data on unmet need, pipeline growth, sales, development economics, technical difficulty and commercial pressure.
Instead of treating each chart as a separate finding, the redesign builds one visual system around the innovation engine:
The result is a presentation that behaves like a diagnosis, not a report summary.
PowerPoint Transformation 03
Healthcare · Vaccine Innovation
10-slide PowerPoint redesign
16 Morph frames · .pptx
Seven transformations. Drag each divider: the left side is a simplified, anonymised drawing of the source structure; the right side is the slide from the finished PowerPoint.
A dense disease-burden dataset becomes one dominant number and one clear message: 600M+ healthy life years lost every year, close to a quarter of the total disease burden.
BEFORE · SOURCE STRUCTUREAFTER · REDESIGN
Source structure: Large disease-burden table, redrawn without its textSlide from the finished .pptx
The data is no longer shown only as growth. 125 → 266 candidates becomes the setup for the contradiction, and the slide ends on a question: so where is the problem?
BEFORE · SOURCE STRUCTUREAFTER · REDESIGN
Source structure: Traditional pipeline-growth chart, redrawn without its textSlide from the finished .pptx
More sales
doesn't mean
more breakthroughs.
The contradiction at the centre of the deck. Two charts that lived pages apart in the source now share one picture, and the picture disagrees with itself.
The market circle splits by area: 74% of sales from existing vaccines, 26% from new launches. Growth and innovation finally appear on the same picture, and they disagree.
BEFORE · SOURCE STRUCTUREAFTER · REDESIGN
Source structure: Sales growth and launch share, shown separately, redrawn without its textSlide from the finished .pptx
Growth in biotech and emerging-market programs becomes visually meaningful only when compared with a fixed commercialisation gate.
BEFORE · SOURCE STRUCTUREAFTER · REDESIGN
Source structure: Three company-type pipeline series, redrawn without its textSlide from the finished .pptx
The point is not to reproduce a quadrant. It is to show that the next opportunities sit farther from the easy corner.
BEFORE · SOURCE STRUCTUREAFTER · REDESIGN
Source structure: Attractiveness vs feasibility framework, redrawn without its textSlide from the finished .pptx
Technical risk, R&D + manufacturing and commercial uncertainty are placed exactly where they constrain the development pipeline.
BEFORE · SOURCE STRUCTUREAFTER · REDESIGN
Source structure: Three pressure drivers, explained separately, redrawn without its textSlide from the finished .pptx
The same pipeline from the cover is reused, but now the bottlenecks are opened. Each lever sits where its bottleneck was: narrative continuity across the whole deck.
BEFORE · SOURCE STRUCTUREAFTER · REDESIGN
Source structure: Potential solutions listed as recommendations, redrawn without its textSlide from the finished .pptx
The strongest design decision in the project: every finding is told as a state of the same innovation engine. The cover sets it running, the middle of the deck strains it, and the close sets it running again.
Research feeds a pipeline. A steady stream comes out the other side.
The market expands. The share from new vaccines does not.
Three sources widen against one gate that stays the same width.
The cover engine returns, now pinched in three places.
The pinches release where they sat. Queues dissolve.
Back to the cover position, running clear.
Five decisions, each one a step from report to argument.
Close details from the finished .pptx. Every diagram, chart and layout on this page is a native PowerPoint object that can be opened, edited and presented.
Three named layouts with kicker, title, source and page placeholders. Theme colours and fonts live in the theme, so the deck restyles in one place.
Sixteen frames for ten slides. Objects share Morph names across frames, so the pinches retract, queues dissolve and the output grows, instead of one slide replacing another.
The widening stream is a native stacked area chart. An invisible offset series centres it, so the data sheet still holds the real values: 125 → 266.
!!eng-funnelfreeform!!eng-piperounded rect!!eng-pt-0 · !!eng-pb-0bottleneck 01!!eng-pt-1 · !!eng-pb-1bottleneck 02!!eng-pt-2 · !!eng-pb-2bottleneck 03!!eng-p-0 … !!eng-p-1516 candidates!!eng-ring · !!eng-outcapacity · outputEngine, flows, gate, field and bubbles are shapes and freeform curves. 400+ editable objects across the ten slides. No images.
0.6 inch margins, one headline position, one source line and one page counter on every content slide. The variety lives inside the grid.
1 · Wipe ↓ ↑bottleneck 01 · technical risk Fadelabel + description2 · Wipe ↓ ↑bottleneck 02 · R&D + manufacturing Fadelabel + description3 · Wipe ↓ ↑bottleneck 03 · commercialSlide 10 · Motion path ∞the engine flows againFade, Wipe and Appear only where they pace the argument. Looping motion paths keep the engine moving on the cover and the close.
The gate, the bottlenecks and the opportunity field are drawn, not pasted: each one can be resized, recoloured or re-sequenced in PowerPoint.
The design
isn't flattened.
The thinking
stays editable.
The key diagrams, data visualisations and layouts remain presentation-ready and editable.
Built in PowerPoint. Not limited by it.
Same pipeline.
Less friction.
PowerPoint Transformation Study
Independent presentation redesign. The source document is confidential and is not reproduced: before views are simplified, anonymised drawings of its slide structures. Figures on the redesigned slides are attributed to the third-party sources cited on each slide. Not commissioned by or affiliated with the original authors.